Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126864042 | 12686404 | 2 | F | 20160412 | 20160412 | 20160825 | 20160912 | PER | US-JAZZ-2016-US-007027 | JAZZ | 40.42 | YR | M | Y | 0.00000 | 20160912 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126864042 | 12686404 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 126864042 | 12686404 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 126864042 | 12686404 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 126864042 | 12686404 | 4 | SS | LOVASTATIN. | LOVASTATIN | 1 | UNK | N | 0 | TABLET | |||||||||
| 126864042 | 12686404 | 5 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 6 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 7 | C | ABILIFY | ARIPIPRAZOLE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 8 | C | Chromium picolinate | CHROMIUM PICOLINATE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 9 | C | CLARITIN | LORATADINE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 10 | C | Ginkgo biloba | GINKGO | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 11 | C | NUVIGIL | ARMODAFINIL | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 12 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 13 | C | Ropinirole hcl | ROPINIROLE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 14 | C | SIMETHICONE (DIMETHICONE) | DIMETHICONE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 15 | C | SUDAFED | PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 16 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 17 | C | UROCIT-K | POTASSIUM CITRATE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 18 | C | VIIBRYD | VILAZODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 19 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 20 | C | ATIVAN | LORAZEPAM | 1 | U | 0 | |||||||||||
| 126864042 | 12686404 | 21 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126864042 | 12686404 | 1 | Narcolepsy |
| 126864042 | 12686404 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126864042 | 12686404 | Drug hypersensitivity | |
| 126864042 | 12686404 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126864042 | 12686404 | 1 | 201308 | 201308 | 0 | |
| 126864042 | 12686404 | 3 | 201309 | 0 | ||
| 126864042 | 12686404 | 4 | 20160206 | 20160329 | 0 |